Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk-Reference-Cited by-同舟云学术

Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk

Published:2022-11 Issue: Volume:1211 Page:123489
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Zuma Phiwe,Joubert Anton,van der Merwe Marthinus,Norman Jennifer,Waitt Catriona,Court Richard,Loveday Marian,Castel Sandra,Wiesner Lubbe

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference32 articles.

1. Centers for Disease Control and Prevention, “Treatment for TB Disease & Pregnancy,” Centers for Disease Control and Prevention, Aug. 13, 2020. https://www.cdc.gov/tb/topic/treatment/pregnancy.htm (accessed Jun. 21, 2022).

2. Drug Excretion in Breast Milk;Vorherr;Postgrad. Med.,1974

3. Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding

4. Antiinfectives in Breastmilk. Part III: Antituberculars, Quinolones and Urinary Germicides;Fulton;J. Hum. Lact.,1993

5. The maternal and fetal effects of tuberculosis therapy;Brost;Obstet. Gynecol. Clin. North Am.,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs in Human Milk Part 1: Practical and Analytical Considerations in Measuring Drugs and Metabolites in Human Milk;Clinical Pharmacokinetics;2024-05

2. THE SIMULTANEOUS QUANTIFICATION OF RIFAMPICIN AND ISONIAZID IN PATIENTS WITH TUBERCULOSIS APPLIED TO VOLUMETRIC ABSORPTIVE MICROSAMPLING DEVICES USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;International Journal of Applied Pharmaceutics;2024-01-07

3. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management;Journal of Pharmaceutical Analysis;2024-01

4. Development, validation, and measurement uncertainty estimation of automated micro‐solid‐phase extraction coupled with liquid chromatography‐triple quadrupole mass spectrometry for the quantitative determination of anti‐tuberculosis drugs in milk samples;SEPARATION SCIENCE PLUS;2023-07-24

5. Best practices for the care of pregnant people living with TB;The International Journal of Tuberculosis and Lung Disease;2023-05-01